
Description SciGen Ltd, a biopharmaceutical company, engages in co-developing and marketing genetically engineered biopharmaceutical products for human healthcare. It focuses in the areas of gastroenterology, endocrinology and immunology. Its product portfolio includes therapeutics, such as rhuman Growth Hormone, rhuman Insulin, and GCSF. The company has rights to manufacture, distribute, and market biopharmaceutical products under exclusive licensing arrangements. Its portfolio includes proprietary biotechnology-derived products, and biosimilar products. The company was founded in 1988 and is headquartered in Singapore. SciGen Ltd. is a subsidiary of BIOTON S.A. To view the detailed information, you need to SUBSCRIBE with us. |
![]() |